Biotechnology giant Moderna, Inc. announced that it has committed to pay its partner Arbutus Biopharma and its subsidiary Genevant Sciences an unconditional one-time payment of up to 950 millions USD on or before July 8, 2026.
Show original
This payment comes with no subsequent conditions, marking an important financial milestone in the cooperation between both parties on the relevant technology platform.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
US judge freezes 70.6 BTC assets in dispute between BlockFills and Dominion Capital
AIcoin•2026/03/05 19:02
Trending news
MoreTevogen Bio Holdings (Tevogen) has recently taken a key step in its generic drug business strategy, signing a letter of intent to officially begin evaluating the potential acquisition of Apozeal Pharmaceuticals.
Tevogen Bio Holdings Inc is currently actively evaluating other transaction opportunities and has strategically focused its priorities on businesses related to the life sciences sector.
Crypto prices
More
Bitcoin
BTC
$71,079.73
-3.25%
Ethereum
ETH
$2,080.35
-4.10%
Tether USDt
USDT
$1
-0.03%
BNB
BNB
$649.41
-1.87%
XRP
XRP
$1.41
-2.87%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$89.01
-4.33%
TRON
TRX
$0.2829
-1.56%
Dogecoin
DOGE
$0.09449
-8.18%
Cardano
ADA
$0.2706
-3.82%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now